Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sneha T. Reddy"'
Autor:
Gwen L. Nichols, Louis J. DeGennaro, Catherine Sanders, Paul A. Fields, Patrick W. Johnson, Jonathon W. Senefeld, Sneha T. Reddy, Jun Xu, Lore M. Gruenbaum, Larry A. Saltzman, Lee M. Greenberger
The anti-spike T-cell and antibody responses to SARS-CoV-2 mRNA vaccines in patients with B-cell malignancies were examined in a real-world setting. A next-generation sequencing (NGS)–based molecular assay was used to assess SARS-CoV-2–specific T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::614add0ab2b21bdbd6019ae4872a2039
https://doi.org/10.1158/2643-3230.c.6550961.v1
https://doi.org/10.1158/2643-3230.c.6550961.v1
Autor:
Gwen L. Nichols, Louis J. DeGennaro, Catherine Sanders, Paul A. Fields, Patrick W. Johnson, Jonathon W. Senefeld, Sneha T. Reddy, Jun Xu, Lore M. Gruenbaum, Larry A. Saltzman, Lee M. Greenberger
Supplementary Figure from Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c663e4a4541fdf58ec5dae0f11dbd16f
https://doi.org/10.1158/2643-3230.22545515.v1
https://doi.org/10.1158/2643-3230.22545515.v1
Autor:
Sophia C Cornew, Anthony B Cardillo, Louis J DeGennaro, Paul A Fields, Lore M Gruenbaum, Hana Littleford, Richard L Martin, Gwen L Nichols, Amanda C Nottke, Conner M O'Brien, Sneha T Reddy, Rhonda Rosenbaum, Larry A Saltzman, Catherine Sanders, Jun Xu, Lee M Greenberger
Publikováno v:
Blood. 140:8044-8045
Autor:
Sneha T Reddy, Larry A Saltzman, Louis J DeGennaro, Gwen L Nichols, Janaela Scott, Jonathon W Senefeld, Patrick W Johnson, Lee M Greenberger
Publikováno v:
Blood. 140:5250-5251
Autor:
Lee M. Greenberger, Larry A. Saltzman, Lore M. Gruenbaum, Jun Xu, Sneha T. Reddy, Jonathon W. Senefeld, Patrick W. Johnson, Paul A. Fields, Catherine Sanders, Louis J. DeGennaro, Gwen L. Nichols
Publikováno v:
Blood cancer discovery. 3(6)
The anti-spike T-cell and antibody responses to SARS-CoV-2 mRNA vaccines in patients with B-cell malignancies were examined in a real-world setting. A next-generation sequencing (NGS)–based molecular assay was used to assess SARS-CoV-2–specific T